Dalhousie Industry Liaison and Innovation Welcomes:
Dan Darnley, Vice President and Chief Intellectual Property Counsel at Millennium Pharmaceuticals, Inc., the Takeda Oncology Company; and Jonathan O’Brien, Ph.D., Partner and Chair of the Intellectual Property Practice Group at Honigman Miller Schwartz and Cohn LLP for a seminar discussion on how best to protect your intellectual property.

Particularly, the focus will be on early stage discoveries and how to make them more attractive to a potential industry partner. The panel will also discuss how new opportunities are evaluated within big pharma/biotech.

When: 11:30 AM -12:30 PM Friday, July 9th, 2010
Where: Room 1009 Rowe Building

Attendees will have an opportunity to have one-on-one time with the distinguished speakers. A light lunch will be provided after the presentation.

Please RSVP to Doris.Grant@dal.ca by July 5th.